Ulrich Aldag

Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA.

BioCision LLC operates as a life science research and development company. Its products include cell cryopreservation systems, sample cooling, freezing, snap-freezing, ice-free cooling systems, tube temperature and plate temperature management, support platforms, sample transport, cryostorage boxes, cryogenic vials, ice pans and buckets and other accessories. The firm’s products protect temperature-sensitive therapeutics, biological samples and biomaterials. The company was founded by Brian Schryver and Rolf O. Ehrhardt in 2007 and is headquartered in San Rafael, CA.

DIB Doblinger Industriebeteiligung GmbH & Co. Holding KG is a private equity firm. The company is based in Munich, Germany.

Hmr is a French company that specializes in the restoration of historic monuments. The private company is based in Tossiat, France. The company offers services such as size stone masonry and hemp lime plaster.

MAN Gutehoffnungshutte AG supplies automobile parts. The private company is based in Oberhausen, Germany.

UniQuest Pty Ltd. operates as a commercialization company of The University of Queensland. It specializes in industry-university collaborations, global technology transfer, and provide access to UQ's world-class expertise, intellectual property, and facilities. The company was founded in July 1984 and is headquartered in Brisbane, Australia.

U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Part of Charles River Laboratories International, Inc., NewLab BioQuality AG is a laboratory services provider that specializes in the analysis of biopharmaceutical drugs. The company is based in Erkrath, Germany. The German company was founded by Jürgen Schumacher. Jürgen Schumacher has been the CEO since incorporation. NewLab BioQuality was acquired by Charles River Laboratories International, Inc. on September 09, 2008 for $52.65 million.

Part of Wölbern Group KG, Wölbern Invest KG is a company based in Hamburg, Germany. Wölbern Invest KG provides fund management services. The German company was founded in 2007. Heinrich Maria Schulte has been the CEO of the company since 2009.

2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.

Medovent GmbH engages in the development and manufacture of medical devices made of the biopolymer chitosan. Its main products are a nerve guide used for peripheral nerve injuries and a direct suture for short nerve defects. The company was founded by Rivelino Montenegro and Thomas Freier in 2006 and is headquartered in Mainz, Germany.

DIREVO Industrial Biotechnology GmbH provides bioengineering services for industrial, molecular biology, and reaction chemistry applications. It offers enzyme and strain engineering, application development, and process engineering services. The firm also offers research and development services for bio-fuel production. The company was founded in July 2008 and is headquartered in Cologne, Germany.

Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA.

SCIENAMICS GmbH offers services for life science companies in the area of scientific marketing, business development and strategic consulting. It offers services for public Sector, academia, investors, pharma and biotech companies. The company was founded by Timm H. Jessen on July 1, 2004 and is headquartered in Schleswig, Germany.

QureInvest AG targets seed and early stage companies located in Germany and Switzerland. It seeks investments in biotechnology and life sciences firms.

Bernhard Schulte GmbH & Co. KG operates as a holding company with interest in ship management industry. It owns 100 vessel and manages about 620 vessels. The company was founded by Konsul Bernhard Schulte on October 1, 1955 and is headquartered in Hamburg, Germany.

Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France.

Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria.

Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia.

AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany.

Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy.

Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia.

MedCision LLC provides medical related software solutions. Its products include ThawSTAR Automated Cell Thawing Systems, BioT Temperature Stability Systems and Custom ULT Freezer Storage Boxes. The firm develops and commercializes technologies that automate and standardize preclinical and clinical biologics handling for critical post-manufacturing processes. The company was founded by Rolf O. Ehrhardt in 2016 and is headquartered in San Rafael, CA.

ETHRIS GmbH is a German company that specializes in developing innovative therapies and vaccines using its proprietary messenger RNA technology platform. The company is based in Planegg, Germany. The company is a leader in delivering stabilized mRNA directly to the respiratory system via optimized formulation and nebulization technologies. ETHRIS is rapidly advancing its pipeline of immuno-modulation, protein replacement therapies, and differentiated vaccines, with the ultimate goal of improving patients' lives. The company was founded by Carsten Rudolph and Christian Plank, and Carsten Rudolph has been the CEO since incorporation.

Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017.

GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy.